Flagship-backed Vesalius lays off 43%

Vesalius Therapeutics, a computational biology startup launched by Cambridge's Flagship Pioneering only six months ago, has laid off 43% of its workforce — 29 employees, a spokeswoman confirmed.

Previous Local partners sell Doughboy Square apartments to Multiversity Housing Partners
Next ZGF, design firm with long history in Colorado, opens office in Denver